Author:
Sayana Shilpa,Khanlou Homayoon
Subject
Virology,Infectious Diseases,Microbiology (medical),Microbiology
Reference22 articles.
1. Treatment for Adult HIV Infection
2. Formulary Submission Dossier of ISENTRESS™ (Raltegravir), received October 24, 2007.
3. Teppler H, Azrolan N, Chen J. Differential effect of MK-0518 and efavirenz on serum lipids and lipoproteins in antiretroviral therapy (ART)-naive patients. Presented at:46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA, USA, 27–30 September 2006 (Abstract H-256a).
4. Metabolism and Disposition in Humans of Raltegravir (MK-0518), an Anti-AIDS Drug Targeting the Human Immunodeficiency Virus 1 Integrase Enzyme
5. Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献